Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System (SUMO)

This study has been completed.
Sponsor:
Collaborator:
Apollo Endosurgery, Inc.
Information provided by (Responsible Party):
Jeffrey Marks, MD, University Hospital Case Medical Center
ClinicalTrials.gov Identifier:
NCT01322737
First received: March 7, 2011
Last updated: December 12, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)